Chang Xu, Tingxu Yan, Shuo Wen, Can Wu, Tingmin Chang, Eryan Kong et al. Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy. // BioDrugs. – 2026. – DOI: 10.1007/s40259-026-00769-x. – URL: https://doi.org/10.1007/s40259-026-00769-x
Chang Xu, Tingxu Yan, Shuo Wen, Can Wu, Tingmin Chang, Eryan Kong, & Huicong Liu (2026). Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy. BioDrugs. https://doi.org/10.1007/s40259-026-00769-x
Chang Xu, et al. “Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.” BioDrugs, 2026. doi:10.1007/s40259-026-00769-x.
@article{Xu2026,
title = {Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy},
author = {Xu, Chang and Yan, Tingxu and Wen, Shuo and Wu, Can and Chang, Tingmin and Kong, Eryan and Liu, Huicong},
journal = {BioDrugs},
year = {2026},
doi = {10.1007/s40259-026-00769-x},
url = {https://doi.org/10.1007/s40259-026-00769-x}
}